ResearcherKyoto UniversityNo recent work listed
Kenji Masuo
Matched on OpenAlex author ID A5033458713. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 17
2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper
Papers 3
- Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. Co-author DOI 10.1038/s41388-023-02716-4↗
- SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. Co-author DOI 10.1111/cas.15162↗
- Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Co-author DOI 10.1136/gutjnl-2017-315425↗
Closest collaborators
The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Hiroshi Seno · 3 shared papers, 2019–2023 · strength 0.34
- Paper Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. DOI 10.1038/s41388-023-02716-4↗
- Paper SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. DOI 10.1111/cas.15162↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Akihisa Fukuda · 3 shared papers, 2019–2023 · strength 0.34
- Paper Brg1 controls stemness and metastasis of pancreatic cancer through regulating hypoxia pathway. DOI 10.1038/s41388-023-02716-4↗
- Paper SNAIL2 contributes to tumorigenicity and chemotherapy resistance in pancreatic cancer by regulating IGFBP2. DOI 10.1111/cas.15162↗
- Paper Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. DOI 10.1136/gutjnl-2017-315425↗
- Toshihiko Masui · 2 shared papers, 2021–2023 · strength 0.27
- Takahisa Maruno · 2 shared papers, 2019–2023 · strength 0.21
- Motoyuki Tsuda · 2 shared papers, 2019–2023 · strength 0.21
- Shinji Üemoto · 2 shared papers, 2019–2021 · strength 0.21
- Shigeo Takaishi · 2 shared papers, 2019–2021 · strength 0.21
- Osamu Araki · 1 shared paper, 2023 · strength 0.14
- Makoto Sono · 1 shared paper, 2023 · strength 0.14
- Etsuro Hatano · 1 shared paper, 2023 · strength 0.14
- Dieter Saur · 1 shared paper, 2023 · strength 0.14
- Yoshito Kimura · 1 shared paper, 2019 · strength 0.07
- Kozo Ikuta · 1 shared paper, 2019 · strength 0.07
- Tsutomu Chiba · 1 shared paper, 2019 · strength 0.07
- Yuto Kimura · 1 shared paper, 2019 · strength 0.07
- Satoshi Ogawa · 1 shared paper, 2019 · strength 0.07
- Kyoichi Takaori · 1 shared paper, 2019 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.